Skip to main content
Tech.euFundingExplorerBeta

AMPLY

AMPLY’s AI drug discovery platform was developed to ensure new generations of antibiotics remain effective against infections.

AMPLY has raised €4.2M across 3 funding rounds from 12 investors, most recently a Seed round in May 2025. Based in Belfast, Ireland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€4.2M
€4,212,834
Funding rounds
3
Investors
12
distinct backers
Active since
2022-09
latest 2025-05

Funding by year

EUR raised per year
AMPLY — funding by year — interactive chart.
Data table
AMPLY — funding by year
2022€1.0M
2024€1.6M
2025€1.5M

Signals

High confidence
Raise-next likelihood55
base rate 44% for Seed
  • ▲ In typical raise window
  • ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds

Similar companies

same sector or country

Global coverage: FundingData